Home / Pharmaceutical company intelligence
Bio-Labs(Pvt) Ltd logo
Pharmaceutical company intelligence

Bio-Labs(Pvt) Ltd

Private pharmaceutical manufacturer · Islamabad · Pakistan

Islamabad-area healthcare manufacturer producing branded pharmaceuticals and animal-health products through GMP-compliant facilities.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Bio-Labs (Pvt.) Ltd
Company type
Private pharmaceutical manufacturer
Address
Plot No. 145, Industrial Triangle, Kahuta Road, Islamabad, Pakistan
Phone
+92 51 8738362-5
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000296 Biolabs (Pvt) Ltd. · Islamabad
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000296 236 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx236public portfolio records represented
REG174unique registrations represented
IDX236indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR236current validated price records
G82generic molecules in indexed catalogue
DF10dosage-form groups
TA13therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage100%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage93%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixBio-Labs(Pvt) LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/bio-labspvt-ltdGenerated 24 Sep 2026Anti-infectives101 · 43%CNS & mental health42 · 18%Gastrointestinal & hepatology24 · 10%Cardiovascular18 · 8%Vitamins, minerals & nutrition13 · 6%Endocrine & metabolic10 · 4%Oncology & immunology9 · 4%Other therapeutic areas19 · 8%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioBio-Labs(Pvt) LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/bio-labspvt-ltdGenerated 24 Sep 2026236presentationsTablet113 · 48%Injection65 · 28%Capsule24 · 10%Suspension11 · 5%Infusion6 · 3%Syrup6 · 3%Other forms11 · 5%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionBio-Labs(Pvt) LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/bio-labspvt-ltdGenerated 24 Sep 2026219comparable productsBelow peer median82 · 37%Near peer median95 · 43%Above peer median42 · 19%Company median price position-0.6%Lowest-price equivalents21Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsBio-Labs(Pvt) LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/bio-labspvt-ltdGenerated 24 Sep 2026Nabiqasim Industries (Pvt) Ltd.,53 shared65% overlapNeutro Pharma (Pvt.) Ltd.,47 shared57% overlapM/s. Genix Pharma (Pvt) Ltd.44 shared54% overlapPharmasol (Pvt) Ltd.43 shared52% overlapMacter International Limited43 shared52% overlapMediate Pharmaceutical Pvt Ltd42 shared51% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives101 products · 43%
CNS & mental health42 products · 18%
Gastrointestinal & hepatology24 products · 10%
Cardiovascular18 products · 8%
Vitamins, minerals & nutrition13 products · 6%
Endocrine & metabolic10 products · 4%
Oncology & immunology9 products · 4%
Hematology & thrombosis5 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins25 products · 11%
Antipsychotics18 products · 8%
Antiemetics16 products · 7%
SSRI antidepressants16 products · 7%
Vitamins / minerals / hematinics12 products · 5%
Macrolide antibacterials12 products · 5%
Fluoroquinolone antibacterials12 products · 5%
Antimalarials9 products · 4%
Formulation footprint

Dosage forms

Tablet113 products
Injection65 products
Capsule24 products
Suspension11 products
Infusion6 products
Syrup6 products
Cream4 products
Ointment3 products
Gel2 products
Lotion2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 TuffCeftriaxone 10presentations 1 g, 2 g, 250 mg, 500 mg · Injection #2 VemtixOndansetron 8presentations 4 mg, 4 mg/2 mL, 8 mg, 8 mg/4 mL · Tablet, Injection #3 AcichekOmeprazole 7presentations 20 mg, 40 mg · Capsule, Injection #4 BiozidCeftazidime 6presentations 1 g, 250 mg, 500 mg · Injection #5 C-OxacinCiprofloxacin 6presentations 100 mg/50 mL, 125 mg/5 mL, 250 mg, 250 mg/5 mL · Infusion, Suspension, Tablet #6 QualeyQuetiapine 6presentations 100 mg, 200 mg, 25 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median8237% of comparable products
Near market median95within ±5% of median
Above market median4219% of comparable products
Lowest-price equivalents21ties included
Company median price position -0.6% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Tranxet 250 mg/5 mLTranexamic acid · Injection · 5ml x 100's PKR 5.05/mL-60.9% vs market median Tranxet 250 mg/5 mLTranexamic acid · Injection · 5ml x 1's PKR 6.00/mL-53.6% vs market median E-Cital 20 mgEscitalopram · Tablet · 28's PKR 31.02/tablet-48.5% vs market median Lagind Injecttion 1 %Lidocaine · Injection · 2ml x 1's PKR 1.89/mL-47.6% vs market median Voritic 200 mgVoriconazole · Injection · 1's PKR 868.59/vial/unit-41.9% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 53shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 47shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 44shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 43shared generics Macter International Limited256 products · 93 generics 43shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 42shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers174Distinct registrations among indexed, published, presentation-validated products only
Verified price observations236
Products with a verified price236
Products with multiple price observations0
Source records with multiple versions234
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jul 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

174 unique registration(s) · 236 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Biotrim Clotrimazole 1 % Cream 10gm 054772 PKR 66.03 PKR 6.60/g 7% above median
Biozid Ceftazidime 250 mg Injection 36's 054574 PKR 5,064.49 PKR 140.68/vial/unit 12% below median
Biozid Ceftazidime 250 mg Injection 1's 054574 PKR 166.58 PKR 166.58/vial/unit Near median
Biozid Ceftazidime 500 mg Injection 36's 054575 PKR 7,756.48 PKR 215.46/vial/unit 11% below median
Biozid Ceftazidime 500 mg Injection 1's 054575 PKR 255.12 PKR 255.12/vial/unit Near median
Biozid Ceftazidime 1 g Injection 36's 054576 PKR 14,554.46 PKR 404.29/vial/unit 12% below median
Biozid Ceftazidime 1 g Injection 1's 054576 PKR 478.72 PKR 478.72/vial/unit Near median
Biozil Cefixime 100 mg/5 mL Dry suspension 30ml 054769 PKR 330.15 PKR 11.01/mL 5% above median
Biozil Cefixime 200 mg/5 mL Dry suspension 30ml 054770 PKR 403.68 PKR 13.46/mL Near median
Biozil Cefixime 400 mg Capsule 1x5's 054771 PKR 591.27 PKR 118.25/capsule Near median
Biozil Cefixime 400 mg Capsule 100's 054771 PKR 9,986.39 PKR 99.86/capsule 11% below median
Biozith Azithromycin 250 mg Tablet 6's 065185 PKR 303.14 PKR 50.52/tablet 8% above median
Biozith Azithromycin 250 mg Tablet 10's 065185 PKR 480.22 PKR 48.02/tablet Near median
Biozith Azithromycin 500 mg Tablet 6's 069912 PKR 555.25 PKR 92.54/tablet 9% above median
Biozith Azithromycin 500 mg Tablet 10's 069912 PKR 879.40 PKR 87.94/tablet Near median
C-Oxacin Ciprofloxacin 250 mg Tablet 10's 046359 PKR 256.62 PKR 25.66/tablet Near median
C-Oxacin Ciprofloxacin 500 mg Tablet 10's 046992 PKR 424.69 PKR 42.47/tablet Near median
C-Oxacin Ciprofloxacin 100 mg/50 mL IV infusion 50ml 075195 PKR 118.55 PKR 2.37/mL Near median
C-Oxacin Ciprofloxacin 400 mg Injection 100ml 075196 PKR 325.65 PKR 3.26/mL No comparator
C-Oxacin Ciprofloxacin 125 mg/5 mL Dry suspension 60ml 077808 PKR 222.36 PKR 3.71/mL Near median
C-Oxacin Ciprofloxacin 250 mg/5 mL Dry suspension 60ml 077809 PKR 316.64 PKR 5.28/mL Near median
C-Oxacin I/V Ciprofloxacin 200 mg Injection 100ml 073085 PKR 196.59 PKR 1.97/mL 23% below median
Ciclorine Cycloserine 250 mg Capsule 30's 105942 PKR 3,241.47 PKR 108.05/capsule 26% below median
Cingenta Gentamicin 40 mg/mL Injection 1ml x 20's 084336 PKR 435.20 PKR 21.76/mL 15% below median
Cingenta Gentamicin 80 mg/2 mL Injection 2ml x 5's 084337 PKR 157.57 PKR 15.76/mL 16% below median
Cingenta Gentamicin 20 mg/mL Injection 2ml x 5's 084366 PKR 79.54 PKR 7.95/mL 68% below median
Cipflox Ciprofloxacin 250 mg Capsule 10's 063405 PKR 262.62 PKR 26.26/capsule Near median
Cipflox Ciprofloxacin 500 mg Capsule 10's 063406 PKR 363.16 PKR 36.32/capsule 15% below median
Citatrio Citalopram 20 mg Tablet 14's 065186 PKR 741.34 PKR 52.95/tablet 7% below median
Coatin Atorvastatin 10 mg Tablet 30's 083518 PKR 761.51 PKR 25.38/tablet 10% below median
Coatin Atorvastatin 10 mg Tablet 10's 083518 PKR 276.91 PKR 27.69/tablet Near median
Coatin Atorvastatin 20 mg Tablet 30's 083528 PKR 1,292.25 PKR 43.08/tablet 11% below median
Coatin Atorvastatin 20 mg Tablet 10's 083528 PKR 467.67 PKR 46.77/tablet Near median
Coatin Atorvastatin 40 mg Tablet 10's 105956 PKR 561.52 PKR 56.15/tablet 25% below median
Colicraft Colistimethate sodium 34 mg IV injection 1's 082407 PKR 1,199.81 PKR 1,199.81/vial/unit No comparator
Colicraft Colistimethate sodium 68 mg IV injection 1's 116314 PKR 2,000.07 PKR 2,000.07/vial/unit No comparator
Colicraft Colistimethate sodium 150 mg IV injection 1's 119142 PKR 4,501.60 PKR 4,501.60/vial/unit No comparator
Colicraft Colistimethate sodium 100 mg IV injection 1's 119143 PKR 3,000.68 PKR 3,000.68/vial/unit No comparator
Defarox Deferasirox 500 mg Dispersible tablet 28's 118874 PKR 8,431.08 PKR 301.11/tablet 37% below median
Defarox Deferasirox 500 mg Dispersible tablet 1's 118874 PKR 301.11 PKR 301.11/tablet 37% below median
Demard Azathioprine 50 mg Tablet 10's 093266 PKR 205.59 PKR 20.56/tablet 26% below median
Demard Azathioprine 50 mg Tablet 100's 093266 PKR 2,051.43 PKR 20.51/tablet 26% below median
E-Cital Escitalopram 10 mg Tablet 30's 046305 PKR 1,532.24 PKR 51.07/tablet Near median
E-Cital Escitalopram 10 mg Tablet 14's 046305 PKR 744.58 PKR 53.18/tablet Near median
E-Cital Escitalopram 20 mg Tablet 28's 118875 PKR 868.59 PKR 31.02/tablet 48% below median
E-Cital Escitalopram 20 mg Tablet 14's 118875 PKR 521.15 PKR 37.23/tablet 38% below median
E-Cital-D Escitalopram 10 mg Tablet 14's 078088 PKR 744.58 PKR 53.18/tablet Near median
Empalozin Empagliflozin 10 mg Tablet 14's 106884 PKR 975.44 PKR 69.67/tablet 16% below median
Empalozin Empagliflozin 25 mg Tablet 14's 106948 PKR 1,167.53 PKR 83.40/tablet 17% below median
Evicar Entecavir 0.5 mg Tablet 3x10's 092101 PKR 9,764.92 PKR 325.50/tablet 9% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Bio-Labs(Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/company/bio-labspvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.